Lown Right Care: Reducing Overuse and Underuse

Overuse of Cardiac Testing

Alan R. Roth, DO, FAAFP, FAAHPM; Andy Lazris, MD, CMD; Sarju Ganatra, MD,


Am Fam Physician. 2018;98(10):560 

In This Article

Resolution of Case

This asymptomatic, 62-year-old white man with hypertension and a 10-year risk of a cardiovascular event of more than 10% would benefit from a low- to moderate-dose statin and low-dose aspirin, according to the USPSTF.[17,18] Further screening for CAD would not be warranted because it has not been shown to reduce mortality, and a coronary artery calcium score to assess for plaque and guide treatment would be considered only if the patient is unable to tolerate statin therapy.